Pharma Focus Asia
KP - Sustainable Packaging Solutions

Cambrex Invests US$16.5 million to Open New R&D Facility

Introduction:
Cambrex  plans to open new R&D manufacturing facility in Minneapolis, USA. It will be located near the Minneapolis–St. Paul Airport.

Features:
The project includes construction of new r&d facility and multi phase expansion.

The new r&d facility will be laid with an area covering of 21,000-square-foot to expand capacity for small molecule development and manufacturing. In addition, multi-phase, 9,000-square-foot expansion and a 21,000-square-foot renovation are also part of the project.

The exapnsion adds a new quality control laboratory and administrative office space. Moreover, the rennovation modernises the current quality control and research and development facilities.

The facility specialised in analytical and chemical process development for pharmaceutical drug candidates will be an extension for Cambrex’s flagship facility in Charles City, Iowa. The new R & D facility is expected to add 40 new jobs in the coming 2-3 years.

Specifications:

NameCambrex
TypeNew Construction
BudgetUS$16.5 million

 

Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?